PH29953A - Substituted 4-phenyl-pyridones and 4-phenyl-3-alkoxypyridines - Google Patents
Substituted 4-phenyl-pyridones and 4-phenyl-3-alkoxypyridinesInfo
- Publication number
- PH29953A PH29953A PH47501A PH47501A PH29953A PH 29953 A PH29953 A PH 29953A PH 47501 A PH47501 A PH 47501A PH 47501 A PH47501 A PH 47501A PH 29953 A PH29953 A PH 29953A
- Authority
- PH
- Philippines
- Prior art keywords
- phenyl
- alkoxypyridines
- substituted
- pyridones
- phenylpyridones
- Prior art date
Links
- DNUDULSSNHKPHP-UHFFFAOYSA-N 4-phenyl-1h-pyridin-2-one Chemical class C1=NC(O)=CC(C=2C=CC=CC=2)=C1 DNUDULSSNHKPHP-UHFFFAOYSA-N 0.000 title abstract 4
- 239000003814 drug Substances 0.000 abstract 4
- 229940079593 drug Drugs 0.000 abstract 2
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/58—Pyridine rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4243278 | 1992-12-21 | ||
| DE4321421A DE4321421A1 (de) | 1992-12-21 | 1993-06-28 | Substituierte 4-Phenyl-pyridone und 4-Phenyl-2-alkoxypyridine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH29953A true PH29953A (en) | 1996-09-16 |
Family
ID=25921579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH47501A PH29953A (en) | 1992-12-21 | 1993-12-20 | Substituted 4-phenyl-pyridones and 4-phenyl-3-alkoxypyridines |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5418243A (xx) |
| EP (1) | EP0603649B1 (xx) |
| JP (1) | JPH06234741A (xx) |
| CN (1) | CN1117965A (xx) |
| AT (1) | ATE140226T1 (xx) |
| AU (1) | AU660132B2 (xx) |
| CA (1) | CA2111778A1 (xx) |
| CZ (1) | CZ284093A3 (xx) |
| DE (1) | DE59303195D1 (xx) |
| DK (1) | DK0603649T3 (xx) |
| ES (1) | ES2089687T3 (xx) |
| FI (1) | FI935728A (xx) |
| GR (1) | GR3020668T3 (xx) |
| HU (1) | HUT70150A (xx) |
| IL (1) | IL108071A0 (xx) |
| MX (1) | MX9308013A (xx) |
| NO (1) | NO934706L (xx) |
| NZ (1) | NZ250500A (xx) |
| PH (1) | PH29953A (xx) |
| PL (1) | PL301582A1 (xx) |
| SK (1) | SK144893A3 (xx) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19627420A1 (de) * | 1996-07-08 | 1998-01-15 | Bayer Ag | 6-(Hydroxymethyl-ethyl)pyridine |
| JP2005126340A (ja) * | 2003-10-22 | 2005-05-19 | Kureha Chem Ind Co Ltd | 置換ピリドン類の製造法、その原料化合物及びその製造方法 |
| TWI417095B (zh) | 2006-03-15 | 2013-12-01 | Janssen Pharmaceuticals Inc | １，４-二取代之３-氰基-吡啶酮衍生物及其作為ｍＧｌｕＲ２-受體之正向異位性調節劑之用途 |
| TW200845978A (en) * | 2007-03-07 | 2008-12-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
| TW200900065A (en) | 2007-03-07 | 2009-01-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives |
| EP2200985B1 (en) * | 2007-09-14 | 2011-07-13 | Ortho-McNeil-Janssen Pharmaceuticals, Inc. | 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones |
| CN101801951B (zh) | 2007-09-14 | 2013-11-13 | 杨森制药有限公司 | 1’,3’-二取代的-4-苯基-3,4,5,6-四氢-2h,1’h-[1,4’]二吡啶-2’-酮 |
| AU2008297877C1 (en) * | 2007-09-14 | 2013-11-07 | Addex Pharma S.A. | 1,3-disubstituted-4-phenyl-1 H-pyridin-2-ones |
| CN101861316B (zh) * | 2007-11-14 | 2013-08-21 | 奥梅-杨森制药有限公司 | 咪唑并[1,2-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途 |
| ES2439291T3 (es) | 2008-09-02 | 2014-01-22 | Janssen Pharmaceuticals, Inc. | Derivados de 3-azabiciclo[3.1.0]hexilo como moduladores de receptores de glutamato metabotrópicos |
| JP5656848B2 (ja) | 2008-10-16 | 2015-01-21 | ジャンセン ファーマシューティカルズ， インコーポレイテッド． | 代謝型グルタミン酸受容体モジュレーターとしてのインドールおよびベンゾモルホリンの誘導体 |
| US8691813B2 (en) | 2008-11-28 | 2014-04-08 | Janssen Pharmaceuticals, Inc. | Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors |
| MX2011011962A (es) | 2009-05-12 | 2012-02-28 | Janssen Pharmaceuticals Inc | Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostericos positivos de receptores de glutamato metabotropico (mglur2). |
| MY153913A (en) | 2009-05-12 | 2015-04-15 | Janssen Pharmaceuticals Inc | 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| ME01573B (me) | 2009-05-12 | 2014-09-20 | Addex Pharma Sa | DERIVATI 1,2,4-TRIAZOLO[4,3-a]PIRIDINA I NJIHOVA UPOTREBA U TRETMANU ILI PREVENCIJI NEUROLOŠKIH I PSIHIJATRIJSKIH POREMEĆAJA |
| AU2011328195B2 (en) | 2010-11-08 | 2015-04-02 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
| US9271967B2 (en) | 2010-11-08 | 2016-03-01 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
| JP5852666B2 (ja) | 2010-11-08 | 2016-02-03 | ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド | １，２，４−トリアゾロ［４，３−ａ］ピリジン誘導体およびｍＧｌｕＲ２受容体のポジティブアロステリックモジュレーターとしてのそれらの使用 |
| JO3368B1 (ar) | 2013-06-04 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2 |
| JO3367B1 (ar) | 2013-09-06 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2 |
| PL3096790T3 (pl) | 2014-01-21 | 2020-01-31 | Janssen Pharmaceutica, N.V. | Kombinacje zawierające pozytywne modulatory allosteryczne lub agonistów ortosterycznych metabotropowego receptora glutaminergicznego podtypu 2 i ich zastosowanie |
| KR20200036063A (ko) | 2014-01-21 | 2020-04-06 | 얀센 파마슈티카 엔.브이. | 대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도 |
| CN104370806B (zh) * | 2014-06-17 | 2017-07-07 | 中国海洋大学 | 一种吡啶酮生物碱类化合物及其制备方法和用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1564502A (en) * | 1975-07-31 | 1980-04-10 | Smith Kline French Lab | Guanidines thioureas and 1,1-diamino-2-nitroethylene derivatives |
| US4156727A (en) * | 1975-07-31 | 1979-05-29 | Smith Kline & French Laboratories Limited | Alkoxy pyridine compounds |
| US4684477A (en) * | 1985-03-06 | 1987-08-04 | Chisso Corporation | Pyridine derivatives and their use in liquid crystals |
| US4906624A (en) * | 1987-09-08 | 1990-03-06 | Warner-Lambert Company | 6-(((Substituted)pyridin-3-yl)alkyl)-and alkenyl)-tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis |
| EP0339342A1 (de) * | 1988-04-23 | 1989-11-02 | Bayer Ag | N-Substituierte N-Amino-pyrrole |
| US4916239A (en) * | 1988-07-19 | 1990-04-10 | Merck & Co., Inc. | Process for the lactonization of mevinic acids and analogs thereof |
| US5032602A (en) * | 1988-12-14 | 1991-07-16 | Bayer Aktiengesellschaft | Inhibiting HMG-CoA reductase with novel substituted 2-pyridones and pyrid-2-thiones |
| DE3909378A1 (de) * | 1989-03-22 | 1990-09-27 | Bayer Ag | Substituierte biphenyle |
| DE3925636A1 (de) * | 1989-08-03 | 1991-02-07 | Bayer Ag | Imino-substituierte pyridine |
-
1993
- 1993-11-25 AU AU51955/93A patent/AU660132B2/en not_active Ceased
- 1993-12-08 ES ES93119766T patent/ES2089687T3/es not_active Expired - Lifetime
- 1993-12-08 DK DK93119766.9T patent/DK0603649T3/da active
- 1993-12-08 AT AT93119766T patent/ATE140226T1/de not_active IP Right Cessation
- 1993-12-08 EP EP93119766A patent/EP0603649B1/de not_active Expired - Lifetime
- 1993-12-08 DE DE59303195T patent/DE59303195D1/de not_active Expired - Fee Related
- 1993-12-14 US US08/166,775 patent/US5418243A/en not_active Expired - Fee Related
- 1993-12-15 MX MX9308013A patent/MX9308013A/es not_active Application Discontinuation
- 1993-12-17 CA CA002111778A patent/CA2111778A1/en not_active Abandoned
- 1993-12-17 IL IL10807193A patent/IL108071A0/xx unknown
- 1993-12-17 NZ NZ250500A patent/NZ250500A/en unknown
- 1993-12-20 PL PL93301582A patent/PL301582A1/xx unknown
- 1993-12-20 CZ CZ932840A patent/CZ284093A3/cs unknown
- 1993-12-20 FI FI935728A patent/FI935728A/fi unknown
- 1993-12-20 NO NO934706A patent/NO934706L/no unknown
- 1993-12-20 HU HU9303675A patent/HUT70150A/hu unknown
- 1993-12-20 JP JP5344533A patent/JPH06234741A/ja active Pending
- 1993-12-20 PH PH47501A patent/PH29953A/en unknown
- 1993-12-20 SK SK1448-93A patent/SK144893A3/sk unknown
- 1993-12-21 CN CN93112965A patent/CN1117965A/zh active Pending
-
1996
- 1996-07-31 GR GR960402026T patent/GR3020668T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SK144893A3 (en) | 1995-02-08 |
| FI935728A0 (fi) | 1993-12-20 |
| FI935728A (fi) | 1994-06-22 |
| AU660132B2 (en) | 1995-06-08 |
| PL301582A1 (en) | 1994-06-27 |
| DE59303195D1 (de) | 1996-08-14 |
| NO934706L (no) | 1994-06-22 |
| NZ250500A (en) | 1996-02-27 |
| CA2111778A1 (en) | 1994-06-22 |
| AU5195593A (en) | 1994-06-30 |
| ATE140226T1 (de) | 1996-07-15 |
| NO934706D0 (no) | 1993-12-20 |
| CZ284093A3 (en) | 1994-07-13 |
| IL108071A0 (en) | 1994-04-12 |
| EP0603649B1 (de) | 1996-07-10 |
| HUT70150A (en) | 1995-09-28 |
| GR3020668T3 (en) | 1996-10-31 |
| DK0603649T3 (da) | 1996-11-04 |
| JPH06234741A (ja) | 1994-08-23 |
| EP0603649A1 (de) | 1994-06-29 |
| MX9308013A (es) | 1994-08-31 |
| US5418243A (en) | 1995-05-23 |
| ES2089687T3 (es) | 1996-10-01 |
| HU9303675D0 (en) | 1994-04-28 |
| CN1117965A (zh) | 1996-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU9303675D0 (en) | Substituted 4-phenyl-pyridone and 4-phenyl-2-alkoxy-pyridine derivatives | |
| ZA937951B (en) | Prodrugs,their preparation and use as pharmaceuticals | |
| IL109578A0 (en) | Nor-bile acid derivatives, processes for their preparation and the use of these compounds as medicaments | |
| AU649421B2 (en) | Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides, drugs containing these compounds and use of such drugs | |
| EP0620004A4 (en) | MEDICAL COMPOSITION. | |
| TW221441B (xx) | ||
| HU9402292D0 (en) | New baccatine-iii and 10-deacetyl-baccatine-iii derivatives, process for producing them and pharmaceutical compositions containing them as active component | |
| DE3874610D1 (xx) | ||
| MY130107A (en) | Piperidylmethyl-substituted chroman derivatives | |
| HUT46659A (en) | Process for producing pyrrolidine-2-(1,3-dicarbonyl) derivatives and pharmaceuticals comprising the same as active ingredient | |
| IL108997A0 (en) | Heterotricyclically substituted phenyl-cyclohexane-carboxylic acid derivatives, their preparation and pharmaceutical compositions containing them | |
| HRP960076B1 (en) | Substituted benzenesulfonylureas and -thioureas, process for their preparation and the use of pharmaceutical preparations based on these compounds, as well as medicaments containing them | |
| IL106289A0 (en) | Phospholipid derivatives, their preparation and pharmaceutical compositions containing them | |
| HU9401914D0 (en) | Piperidine- and piperazine derivatives, pharmaceutical compositions containing them as active components and process for producing both | |
| IL89401A0 (en) | Medicaments containing 1,4-dihydropyridine derivatives for the treatment of alcohol addiction | |
| ATE147741T1 (de) | Substituierte pyridine als hmg-coa-reduktase- inhitoren | |
| HUT45228A (en) | Process for producing isoprene derivatives and pharmaceuticals comprising the same as active ingredient | |
| GR920100423A (el) | Ανταγωνιστές 5-ΗΤ4 κινολιζιδινυλ εστέρος. |